These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 344114)

  • 1. beta-cell function in children with diabetes.
    Ludvigsson J; Heding LG
    Diabetes; 1978; 27 Suppl 1():230-4. PubMed ID: 344114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide in juvenile diabetes.
    Ludvigsson J; Heding LG
    Acta Paediatr Scand Suppl; 1977; (270):53-62. PubMed ID: 356517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assay of C-peptide in diabetes in children and adolescents].
    Jos J; Kestenbaum S
    Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide in children with juvenile diabetes. A preliminary report.
    Ludvigsson J; Heding LG
    Diabetologia; 1976 Dec; 12(6):627-30. PubMed ID: 1001852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
    Ludvigsson J; Heding L
    Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.
    Schober E; Schernthaner G; Frisch H; Fink M
    J Endocrinol Invest; 1984 Oct; 7(5):507-12. PubMed ID: 6392401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
    Ludvigsson J; Heding LG; Larsson Y; Leander E
    Acta Paediatr Scand; 1977 Mar; 66(2):177-84. PubMed ID: 402787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.
    Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I
    Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C; Diosdado MA
    Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinitial remission in diabetic children--an analysis of 178 cases.
    Knip M; Säkkinen A; Huttunen NP; Käär ML; Länkelä S; Mustonen A; Akerblom HK
    Acta Paediatr Scand; 1982 Nov; 71(6):901-8. PubMed ID: 6760664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-types, C-peptide and insulin antibodies in juvenile diabetes.
    Ludvigsson J; Säfwenberg J; Heding LG
    Diabetologia; 1977 Jan; 13(1):13-7. PubMed ID: 838199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.
    Madsbad S; Krarup T; Reguer L; Faber OK; Binder C
    Diabetologia; 1981 May; 20(5):530-4. PubMed ID: 7026327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
    Faber OK
    Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.
    Madsbad S; Bottazzo GF; Cudworth AG; Dean B; Faber OK; Binder C
    Diabetologia; 1980 Jan; 18(1):45-7. PubMed ID: 6988264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional rest through intensive treatment with insulin and potassium channel openers preserves residual beta-cell function and mass in acutely diabetic BB rats.
    Rasmussen SB; Sørensen TS; Hansen JB; Mandrup-Poulsen T; Hornum L; Markholst H
    Horm Metab Res; 2000 Jul; 32(7):294-300. PubMed ID: 10965937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.